Perinatal effects of nicotine

Area of Science:

• Perinatal toxicology
• Reproductive toxicology
• Pharmacology

Background:

• Nicotine is a primary alkaloid in tobacco smoke.
• Maternal smoking during pregnancy is a significant public health concern.
• Understanding nicotine's specific impact on different pregnancy stages is crucial.

Purpose of the Study:

• To investigate the effects of varying nicotine doses on perinatal outcomes in pregnant mice.
• To determine the most vulnerable stage of gestation to nicotine exposure.
• To assess nicotine's impact on gestation length, delivery rates, offspring sex ratio, and perinatal mortality.

Main Methods:

• Three groups of pregnant Swiss albino mice received daily subcutaneous nicotine doses (900, 1,800, 2,700 µg/kg).
• Nicotine administration occurred during each of the three trimesters of pregnancy.
• Observed perinatal effects included gestation period, delivery success, offspring sex ratio, stillbirths, and neonatal deaths.

Main Results:

• Nicotine administration generally increased perinatal mortality across all doses and trimesters.
• Significant shortening of the gestation period was observed with high nicotine doses, especially in the second and third trimesters (p < 0.05; p < 0.01).
• The study identified late pregnancy stages as particularly sensitive to nicotine's adverse effects.

Conclusions:

• Maternal nicotine exposure negatively impacts perinatal outcomes, including increased mortality and shortened gestation.
• Late pregnancy (second and third trimesters) appears most vulnerable to nicotine-induced adverse effects.
• Pregnant individuals should be strongly advised against smoking due to the demonstrated risks to fetal development and survival.